OTCMKTS:TLLTF

TILT Competitors

$0.54
0.00 (0.00 %)
(As of 05/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.52
$0.55
50-Day Range
$0.50
$0.59
52-Week Range
$0.22
$0.75
Volume268,282 shs
Average Volume823,010 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

TILT (OTCMKTS:TLLTF) Vs. TGIFF, FFNTF, ABSCF, ACRDF, ACRHF, and AGFAF

Should you be buying TLLTF stock or one of its competitors? Companies in the industry of "drug manufacturers—specialty & generic" are considered alternatives and competitors to TILT, including 1933 Industries (TGIFF), 4Front Ventures (FFNTF), AB Science (ABSCF), Acreage (ACRDF), Acreage (ACRHF), and AgraFlora Organics International (AGFAF).

1933 Industries (OTCMKTS:TGIFF) and TILT (OTCMKTS:TLLTF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for 1933 Industries and TILT, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
1933 Industries01002.00
TILT00203.00

TILT has a consensus target price of $1.25, indicating a potential upside of 131.57%. Given TILT's stronger consensus rating and higher possible upside, analysts clearly believe TILT is more favorable than 1933 Industries.

Profitability

This table compares 1933 Industries and TILT's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
1933 IndustriesN/AN/AN/A
TILTN/AN/AN/A

Earnings & Valuation

This table compares 1933 Industries and TILT's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
1933 IndustriesN/AN/AN/AN/AN/A
TILTN/AN/AN/AN/AN/A

Summary

TILT beats 1933 Industries on 3 of the 3 factors compared between the two stocks.

4Front Ventures (OTCMKTS:FFNTF) and TILT (OTCMKTS:TLLTF) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.

Earnings & Valuation

This table compares 4Front Ventures and TILT's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
4Front VenturesN/AN/AN/AN/AN/A
TILTN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of current recommendations and price targets for 4Front Ventures and TILT, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4Front Ventures0000N/A
TILT00203.00

TILT has a consensus price target of $1.25, suggesting a potential upside of 131.57%. Given TILT's higher possible upside, analysts plainly believe TILT is more favorable than 4Front Ventures.

Profitability

This table compares 4Front Ventures and TILT's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
4Front VenturesN/AN/AN/A
TILTN/AN/AN/A

Summary

TILT beats 4Front Ventures on 2 of the 2 factors compared between the two stocks.

TILT (OTCMKTS:TLLTF) and AB Science (OTCMKTS:ABSCF) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Profitability

This table compares TILT and AB Science's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
TILTN/AN/AN/A
AB ScienceN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations for TILT and AB Science, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
TILT00203.00
AB Science00103.00

TILT currently has a consensus target price of $1.25, suggesting a potential upside of 131.57%. Given TILT's higher probable upside, equities research analysts clearly believe TILT is more favorable than AB Science.

Valuation and Earnings

This table compares TILT and AB Science's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TILTN/AN/AN/AN/AN/A
AB ScienceN/AN/AN/AN/AN/A

Summary

TILT beats AB Science on 2 of the 2 factors compared between the two stocks.

Acreage (OTCMKTS:ACRDF) and TILT (OTCMKTS:TLLTF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk and analyst recommendations.

Profitability

This table compares Acreage and TILT's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
TILTN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Acreage and TILT, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage00103.00
TILT00203.00

Acreage currently has a consensus target price of $6.00, indicating a potential upside of 140.96%. TILT has a consensus target price of $1.25, indicating a potential upside of 131.57%. Given Acreage's higher probable upside, analysts plainly believe Acreage is more favorable than TILT.

Valuation & Earnings

This table compares Acreage and TILT's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
TILTN/AN/AN/AN/AN/A

TILT (OTCMKTS:TLLTF) and Acreage (OTCMKTS:ACRHF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation.

Earnings & Valuation

This table compares TILT and Acreage's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TILTN/AN/AN/AN/AN/A
AcreageN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and price targets for TILT and Acreage, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
TILT00203.00
Acreage01002.00

TILT currently has a consensus price target of $1.25, suggesting a potential upside of 131.57%. Acreage has a consensus price target of $7.00, suggesting a potential upside of 30.84%. Given TILT's stronger consensus rating and higher probable upside, equities analysts plainly believe TILT is more favorable than Acreage.

Profitability

This table compares TILT and Acreage's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
TILTN/AN/AN/A
AcreageN/AN/AN/A

Summary

TILT beats Acreage on 3 of the 3 factors compared between the two stocks.

AgraFlora Organics International (OTCMKTS:AGFAF) and TILT (OTCMKTS:TLLTF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, risk, institutional ownership, earnings and analyst recommendations.

Profitability

This table compares AgraFlora Organics International and TILT's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AgraFlora Organics InternationalN/AN/AN/A
TILTN/AN/AN/A

Analyst Ratings

This is a breakdown of current ratings and target prices for AgraFlora Organics International and TILT, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AgraFlora Organics International0000N/A
TILT00203.00

TILT has a consensus price target of $1.25, suggesting a potential upside of 131.57%. Given TILT's higher probable upside, analysts clearly believe TILT is more favorable than AgraFlora Organics International.

Valuation & Earnings

This table compares AgraFlora Organics International and TILT's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AgraFlora Organics InternationalN/AN/AN/AN/AN/A
TILTN/AN/AN/AN/AN/A

Summary

TILT beats AgraFlora Organics International on 2 of the 2 factors compared between the two stocks.


TILT Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
1933 Industries logo
TGIFF
1933 Industries
0.0$0.08flat$0.00N/A0.00News Coverage
4Front Ventures logo
FFNTF
4Front Ventures
0.0$1.33flat$0.00N/A0.00
AB Science logo
ABSCF
AB Science
0.8$18.95flat$0.00N/A0.00
Acreage logo
ACRDF
Acreage
1.7$2.49flat$0.00N/A0.00
Acreage logo
ACRHF
Acreage
0.6$5.35flat$0.00N/A0.00
AgraFlora Organics International logo
AGFAF
AgraFlora Organics International
0.8$0.02flat$0.00N/A0.00News Coverage
Aleafia Health logo
ALEAF
Aleafia Health
0.0$0.44flat$0.00N/A0.00Upcoming Earnings
Increase in Short Interest
American Green logo
ERBB
American Green
1.0$0.01flat$0.00N/A0.00
Ayr Wellness logo
AYRWF
Ayr Wellness
1.3$28.48flat$0.00N/A0.00Gap Up
Benchmark logo
BHCCF
Benchmark
1.0$0.79flat$0.00N/A0.00
Bespoke Extracts logo
BSPK
Bespoke Extracts
0.0$0.02flat$0.00N/A0.00
BOSQF
Better Plant Sciences
0.8$0.06flat$0.00N/A0.00Gap Down
BioGaia AB (publ) logo
BIOGY
BioGaia AB (publ)
0.0$25.39flat$0.00N/A0.00
Biome Grow logo
BIOIF
Biome Grow
0.0$0.07flat$0.00N/A0.00Gap Up
BIOYF
BioSyent
0.4$6.07flat$0.00N/A0.00
BioTech Medics logo
BMCS
BioTech Medics
0.0$0.06flat$0.00N/A0.00Gap Down
BOIRF
Boiron
0.0$41.40flat$0.00N/A0.00
Cannabis Global logo
CBGL
Cannabis Global
0.0$0.10flat$0.00N/A0.00Gap Up
NUGS
Cannabis Strategic Ventures
1.0$0.10flat$0.00N/A0.00Gap Down
CSUI
Cannabis Suisse
0.0$0.08flat$0.00N/A0.00Gap Up
CannAmerica Brands logo
CNNXF
CannAmerica Brands
0.0$0.04flat$0.00N/A0.00
Cardiol Therapeutics logo
CRTPF
Cardiol Therapeutics
0.5$3.15flat$0.00N/A0.00Decrease in Short Interest
Gap Up
CBDL
CBD Life Sciences
0.0$0.00flat$0.00N/A0.00
CHNC
China Infrastructure Construction
0.0$0.00flat$0.00N/A0.00
MOTNF
Clean Power Capital
0.0$1.04flat$0.00N/A0.00News Coverage
Gap Up
Columbia Care logo
CCHWF
Columbia Care
1.3$6.33flat$0.00N/A0.00Gap Up
Creso Pharma logo
COPHF
Creso Pharma
0.0$0.16flat$0.00N/A0.00Gap Down
Decibel Cannabis logo
DBCCF
Decibel Cannabis
0.7$0.15flat$0.00N/A0.00Gap Down
DLTNF
Delta 9 Cannabis
1.0$0.45flat$0.00N/A0.00Increase in Short Interest
Delta 9 Cannabis logo
VRNDF
Delta 9 Cannabis
1.2$0.44flat$0.00N/A0.00Gap Up
FTEG
For The Earth
0.0$0.00flat$0.00N/A0.00Gap Down
Green Hygienics logo
GRYN
Green Hygienics
0.0$1.04flat$0.00N/A0.00Gap Up
AGEEF
Halo Labs
0.0$0.07flat$0.00N/A0.00Gap Up
WSLFF
Halo Labs
0.6$0.15flat$0.00N/A0.00Gap Down
Hempfusion Wellness logo
CBDHF
Hempfusion Wellness
0.0$0.96flat$0.00N/A0.00
Heritage Cannabis logo
HERTF
Heritage Cannabis
0.0$0.09flat$0.00N/A0.00News Coverage
Gap Down
HLTRF
HLS Therapeutics
1.7$15.00flat$0.00N/A0.00
Indiva logo
NDVAF
Indiva
1.7$0.33flat$0.00N/A0.00Gap Up
IRCLF
InterCure
0.0$6.40flat$0.00N/A0.00Analyst Report
High Trading Volume
IONKF
Ionic Brands
1.0$0.12flat$0.00N/A0.00Gap Up
Isracann Biosciences logo
ISCNF
Isracann Biosciences
0.0$0.22flat$0.00N/A0.00
Jushi logo
JUSHF
Jushi
0.9$6.86flat$0.00N/A0.00Gap Up
Juva Life logo
JUVAF
Juva Life
0.0$0.60flat$0.00N/A0.00
KSPHF
Kissei Pharmaceutical
0.4$20.57flat$0.00N/A0.00
Lobe Sciences logo
GTSIF
Lobe Sciences
0.0$0.10flat$0.00N/A0.00Gap Down
Medexus Pharmaceuticals logo
MEDXF
Medexus Pharmaceuticals
1.0$6.10flat$0.00N/A0.00News Coverage
PDDPF
Medexus Pharmaceuticals
1.3$3.22flat$0.00N/A0.00Gap Up
MJTV
MJ Biotech
0.0$0.00flat$0.00N/A0.00Gap Down
MPXOF
MPX International
0.5$0.09flat$0.00N/A0.00Gap Down
Mydecine Innovations Group logo
MYCOF
Mydecine Innovations Group
0.0$0.32flat$0.00N/A0.00
This page was last updated on 5/6/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.